Market Cap (In HKD)
241.63 Million
Revenue (In HKD)
1.06 Billion
Net Income (In HKD)
24.12 Million
Avg. Volume
72.53 Thousand
- Currency
- HKD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.121-0.176
- PE
- -
- EPS
- -
- Beta Value
- 0.218
- ISIN
- CNE100000775
- CUSIP
- Y7742Z103
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Feng Zhang
- Employee Count
- -
- Website
- https://www.interlong.com
- Ipo Date
- 2005-09-12
- Details
- Shenzhen Neptunus Interlong Bio-technique Company Limited, together with its subsidiaries, researches, develops, produces, and sells medicines in the People's Republic of China. It is also involved in the purchase, sale, and distribution of medicines and healthcare food products; and research and development of biological technology products. In addition, the company manufactures herbal medicines and generic drugs products, as well as medical devices. The company is based in Shenzhen, the People's Republic of China. Shenzhen Neptunus Interlong Bio-technique Company Limited is a subsidiary of Shenzhen Neptunus Bio-engineering Company Limited.
More Stocks
-
DQWSDSwiss, Inc.
DQWS
-
1860Toda Corporation
1860
-
8426Redwood Group Ltd
8426
-
TPK
-
RATO-BRatos AB (publ)
RATO-B
-
MS-PLMorgan Stanley
MS-PL
-
MQBKYMacquarie Group Limited
MQBKY
-
0613